Vanessa Chaire

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas

Audrey Laroche‐Clary, Vanessa Chaire, Marie-Paule Algéo et al. · Journal of Hematology & Oncology · 2017 · 115 citations · Full text

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies

Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke et al. · EBioMedicine · 2020 · 56 citations · Full text

MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas

Audrey Laroche, Vanessa Chaire, Marie-Paule Algéo et al. · Oncotarget · 2017 · 36 citations · Full text

PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53

Thomas Grellety, Audrey Laroche‐Clary, Vanessa Chaire et al. · BMC Cancer · 2015 · 33 citations · Full text

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas

Audrey Laroche, Vanessa Chaire, François Le Loarer et al. · Journal of Hematology & Oncology · 2017 · 28 citations · Full text